Chemeq founder plans $5m IPO

22/09/2015 - 16:03

Bookmark

Upgrade your subscription to use this feature.

A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options